483 Teva Womens Health Jan 2018

483 Teva Womens Health Jan 2018

Kenneth Felkley FDA, Nicholas Paulin FDA, Lindsey Schwierjohann FDA$595.00 - Available Now

FDA investigators audited the Teva Womens Health - Cincinnati, OH, United States facility and issued inspectional observations (via FDA 483) on 26 Jan 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 26 Jan 2018
  • Location: Cincinnati, United States
  • FEI: 1526814
Add To Cart